Dew, what's your opinion on FMI at this level? 1.Rate of growth in test numbers? Do you think Roche will add test numbers significantly? 2.Pps? fair at this price in valuation? Pharma business seems to be intact. 3. Nationwide coverage? Will it eventually be achieved? No additional coverage by private carriers to start with. 4.Roche. Do you think Roche still has compelling reasons to take over the rest of FMI? TIA, Onemodolar.